Coverage
-
February 20, 2020
A Delaware federal judge on Thursday rejected Abbott Laboratories' bid to dismiss a suit by former stockholders of Tendyne Holdings Inc. claiming that a merger contract breach cost them $50 million, ruling the amended complaint alleges enough facts to keep the suit alive that the original complaint lacked.
1 other articles on this case.
View all »